StockNews.AI
AGL
StockNews.AI
6 hrs

AGILON INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Encourages Investors in Agilon Health, Inc. to Contact the Firm

1. Bragar Eagel & Squire is investigating Agilon for potential securities law violations. 2. Agilon's CEO resignation surprised the market, leading to a 27% stock price drop. 3. The inquiry focuses on disclosures related to leadership and earnings guidance withdrawal. 4. Investors affected by losses are encouraged to discuss legal options with the firm.

4m saved
Insight
Article

FAQ

Why Very Bearish?

The substantial share price drop post-CEO resignation signals investor panic and decreased confidence.

How important is it?

The ongoing investigation and legal exposure are highly relevant to AGL's current valuation.

Why Short Term?

Immediate concerns over leadership instability and legal issues may substantially impact AGL’s short-term prices.

Related Companies

AGLSPYHLTH
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Agilon and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Agilon Health, Inc. (“Agilon” or the “Company”) (NYSE:AGL) on behalf of Agilon stockholders. Our investigation concerns whether Agilon has violated the federal securities laws and/or engaged in other unlawful business practices. Investigation Details: On August 4, 2025, Agilon Health, Inc. announced that its President, Chief Executive Officer, and Board Director, Steven Sell, had resigned from all positions. The Company also released its second-quarter 2025 financial results and withdrew its previously issued full-year 2025 earnings guidance. These disclosures came as a surprise to the market, and the Company’s share price fell by more than 27% in after-hours trading. The investigation focuses on whether Agilon failed to disclose information material to investors, specifically regarding the timing, circumstances, or implications of its leadership transition and guidance withdrawal, despite prior public statements, thereby potentially violating federal securities laws. Next Steps: If you purchased or otherwise acquired Agilon shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, P.C.Brandon Walker, Esq.Marion Passmore, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com

Related News